Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Massachusetts General Hospital, Boston, U.S.
Ovarian cancer stem cells identified; may shed light on recurring tumors
August 18th, 2006
Massachusetts General Hospital (MGH) researchers have identified potential ovarian cancer stem cells, which may be behind the difficulty of preventing tumor recurrance with standard chemotherapy. Understanding more about the stem-like characteristics of these cells could lead to new approaches to treating ovarian cancer, which kills more than 16,000 U.S. women annually and is their fifth most common cause of cancer death. The report appears in Proceeding of the National Academy of Sciences (PNAS) . "We feel these stem-like cancer cells may be resistant to traditional chemotherapy and could be responsible for the ultimately fatal...
Source: Biotech Law Weekly (2006-08-18)
|
